Clinical Trials Directory

Trials / Unknown

UnknownNCT04758806

Fecal Microbial Transplantation in Severe Alcoholic Hepatitis

Fecal Microbial Transplantation for Corticosteroids Non-responders and Non-eligible Patients With Severe Alcoholic Hepatitis

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

1. A subtype of Alcoholic hepatitis (AH), named severe alcoholic hepatitis (SAH) is associated with high short-term mortality (J Hepatol, 2019) 2. The only SAH treatment option - corticosteroids (CS) - are often contraindicated or ineffective (STOPAH Trial) 3. New treatment modalities for remaining patients are much needed 4. Fecal microbial transplantation (FMT) is one of the promising therapies 5. Investigators aimed to see if FMT improves survival in patients admitted with SAH, not responding to-, or non-eligible for CS.

Detailed description

* FMT via upper GI tract is provided to CS non-responders (NR) or non-eligible (NE) adult patients hospitalized with SAH (determined by the Lille-model). * Modified version of the Sarin FMT protocol is used with microbiota material procured from unrelated healthy donors.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFecal microbial transplantationProcured faeces procured from unrelated donor

Timeline

Start date
2018-04-01
Primary completion
2021-12-30
Completion
2022-12-30
First posted
2021-02-17
Last updated
2022-08-03

Locations

1 site across 1 country: Slovakia

Source: ClinicalTrials.gov record NCT04758806. Inclusion in this directory is not an endorsement.